Sign In
Buy CDNA
$38.37
-1.36 (-3.42%)
At Close: Jul 20, 2026
CareDx Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
04:10pm, Friday, 03'rd May 2024
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of cl
CareDx to Report First Quarter 2024 Financial Results
04:05pm, Monday, 29'th Apr 2024
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healt
CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Friday, 19'th Apr 2024
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of cl
CareDx (CDNA) Moves 5.5% Higher: Will This Strength Last?
04:51am, Thursday, 18'th Apr 2024
CareDx (CDNA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in t
CareDx Appoints John W. Hanna as its New President and Chief Executive Officer
04:02pm, Tuesday, 16'th Apr 2024
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of cl
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA)- The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clini
How CareDx (CDNA) Stock Stands Out in a Strong Industry
09:41am, Monday, 01'st Apr 2024
CareDx (CDNA) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
CareDx Appoints Bryan Riggsbee to Its Board of Directors
04:10pm, Monday, 11'th Mar 2024
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of cl
CareDx, Inc. (CDNA) Q4 2023 Earnings Call Transcript
10:22pm, Wednesday, 28'th Feb 2024
CareDx, Inc. (CDNA) Q4 2023 Earnings Call Transcript
CareDx (CDNA) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
08:01pm, Wednesday, 28'th Feb 2024
Although the revenue and EPS for CareDx (CDNA) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Stree
CareDx Announces Fourth Quarter and Full Year 2023 Financial Results
04:05pm, Wednesday, 28'th Feb 2024
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) today reported financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter and Full Year 2023 Highligh
Unlocking Q4 Potential of CareDx (CDNA): Exploring Wall Street Estimates for Key Metrics
10:21am, Monday, 26'th Feb 2024
Beyond analysts' top -and-bottom-line estimates for CareDx (CDNA), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter
CareDx to Report Fourth Quarter and Full Year 2023 Financial Results
04:05pm, Wednesday, 21'st Feb 2024
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healt
CareDx Showcases Digital Solutions and Pipeline in Cellular Transplant and Therapy Monitoring at the 2024 Tandem Meetings
07:00am, Wednesday, 21'st Feb 2024
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) —The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of cli
CareDx Issues Statement in Patent Infringement Case
09:45pm, Friday, 26'th Jan 2024
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healt
